Article updated and reviewed by Christos Ballas, MD, Attenting Psychiatrist, Inpatient and Consult/Liaison Psychiatry, Hospital of the University of Pennsylvania. Editorial review provided by VeriMed Healthcare Network on May 11, 2005.
Recently, the medication Abilify (aripiprazole) was approved by the FDA for the treatment of schizophrenia in the adolescent population... Read more »
Abilify is an atypical antipsychotic (which simply means it is a newer antipsychotic than the original group) which may be used to treat... Read more »
EnVivo Pharmaceuticals announced data in Neuropharmacology that indicate its compound EVP-6124 restored memory loss and improved memory... Read more »
This SharePost is the first of a series devoted to schizophrenia treatment and it focuses specifically on some of the newer drugs used to... Read more »
The precise cause of childhood schizophrenia is not known. As with adult schizophrenia there is an assumed relationship between genetic... Read more »
Source: ADAM Encyclopedia
ReferencesAleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory... Read more »
Source: ADAM Encyclopedia
Schizophrenia can have a devastating effect on both patients and their families.Self-Destructive BehaviorsSubstance Abuse. Many people with... Read more »
Source: ADAM Encyclopedia
of SchizophreniaSchizophrenia can have a devastating impact on patients and their families. Patients with schizophrenia have increased risk for... Read more »
Source: ADAM Encyclopedia
Schizophrenia is categorized as a brain disease, not a psychological disorder, Drug treatment is the primary therapy. Studies indicate, however, that... Read more »
Source: ADAM Encyclopedia
Atypical Antipsychotic DrugsTen atypical antipsychotic drugs are currently approved in the United States:Clozapine (Clozaril, generic)Risperidone... Read more »